PolarCool

The med-tech company PolarCool AB (publ.) continues its successful expansion of PolarCap® in European ice hockey, with the company signing two agreements in the German professional league DEL. ERC Ingolstadt and Straubing Tigers will both adopt treatment with the PolarCap® System into their concussion management routines.

PolarCool develops and markets the product PolarCap® System, which alleviates the effects of concussion. The primary users of PolarCap® System include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion.

PolarCool has previously established strategic collaborations in German ice hockey with professional clubs Adler Mannheim, Eisbären Berlin and Dresdner Eislöwen. With the addition of ERC Ingolstadt and Straubing Tigers, treatment with PolarCap® is now provided by five major German ice hockey clubs. The two clubs will use the PolarCap® for an initial evaluation period, with the option to continue into a two-year commercial agreement.

PolarCool CEO Erik Andersson comments:

-We view the development in German ice hockey very positively and I am pleased that yet two more ice hockey clubs have chosen to sign agreements for the use of PolarCap®. We foresee that the increased awareness of our treatment method provides opportunities for further agreements in this market.

The agreements with ERC Ingolstadt and Straubing Tigers reflects PolarCool's overall strategy to introduce PolarCap® System to the international ice hockey market and marks important strategic progress for PolarCool even if the financial impact of individual agreements is limited.